Gerresheimer includes Stevanato Group integrated twist-off closure system solution for Gx RTF syringes

Gerresheimer will offer its Gx RTF syringes with SG ITC (Integrated Tip Cap) twist-off closure of the Stevanato Group. With this technology, which is often asked for on the market, Gerresheimer includes an especially user-friendly system solution for Luer Lock syringes in its program.

The integrated seal cap consists of two components: an elastomeric component, which is available in different formulations and a rigid, translucent polymer cap. The elastomer component is inserted into the plastic cap, screwed together with a Luer Lock adapter, and pre-assembled on the syringe. Compared to traditional Luer Cone systems, this solution offers a syringe closure with increased stability, thus protecting the drug product. The twist-off closure system responds to the containment needs of different drugs: vaccines, hyaluronic acid, biotech drugs and other viscous drugs. It has been developed and produced according to ISO 11040-7 standard and fit perfect on Gx RTF syringes. Gerresheimer will offer 1.0 ml long and 1.0 ml short Luer Lock syringes with the integrated twist-off closure in the first step. Additional formats will follow.

Increased safety and user-friendliness for medical specialists


The seal cap is securely screwed onto the Gerresheimer Luer Lock syringe, so that accidental removal of the cap is prevented. The familiar twist-off function offers medical specialists improved user-friendliness without impairing the integrity of the pre-fillable syringes. The structured surface simplifies the removal of the cap. “We combine our syringes with system components that are primarily aimed at user-friendliness and safety,” Manfred Baumann (Global Executive Vice President Sales & Marketing, Administration & TCC, Member of the Management Board, Gerresheimer Regensburg GmbH) explains. “The new SG ITC twist-off closure suits these aims outstandingly.” Gerresheimer already delivers syringes equipped with the seal cap, which can be processed on existing filling lines, under the name Gx TWILC (Twistable Integrated Luer lock Closure). The 100-hole nests are packaged in a tub and sterilized with ethylene oxide gas (EtO).

Über die Gerresheimer AG

Gerresheimer is a leading global partner of the pharmaceuticals and health care industries. We contribute to health and well-being with our special products of glass and plastic. We are represented worldwide and, with around 10,000 employees, produce there where our customers and markets are. With our works in Europe, North and South America, and Asia, we achieve turnover of around 1.4 billion Euro. The broad range of our offering encompasses pharmaceutical packaging, as well as products for the simple and safe administering of medication: insulin pens, inhalers, micropumps, pre-fillable syringes, injection vials, ampules, bottles, and containers for liquid and solid medications with seal and safety systems, as well as packaging for the cosmetics industry.

Firmenkontakt und Herausgeber der Meldung:

Gerresheimer AG
Klaus-Bungert-Straße 4
40468 Düsseldorf
Telefon: +49 (211) 6181-00
Telefax: +49 (211) 6181-295
http://www.gerresheimer.de

Ansprechpartner:
Marion Stolzenwald
Senior Manager Group Communication
Telefon: +49 (211) 6181-246
Fax: +49 (211) 6181-241
E-Mail: m.stolzenwald@gerresheimer.com
Karin Fischer
Communication & Marketing Medical Plastic Systems
Telefon: +49 (9431) 639-6140
Fax: +49 (9431) 79838-6140
E-Mail: k.fischer@gerresheimer.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel